...
首页> 外文期刊>The Journal of Pharmacology and Experimental Therapeutics: Official Publication of the American Society for Pharmacology and Experimental Therapeutics >Effects of EM574 and cisapride on gastric contractile and emptying activity in normal and drug-induced gastroparesis in dogs.
【24h】

Effects of EM574 and cisapride on gastric contractile and emptying activity in normal and drug-induced gastroparesis in dogs.

机译:EM574和西沙必利对正常和药物诱发的胃轻瘫患者胃收缩和排空活性的影响。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

EM574, an erythromycin derivative and potent motilin receptor agonist, is now undergoing clinical trials as a gastroprokinetic drug. The aim of this study was to compare the effect of EM574 with that of cisapride on gastric motility and emptying in normal and gastroparesis dogs. Six dogs were each implanted with two duodenal cannulas for infusion of phenolsulfonphthalein into the proximal duodenum and for aspiration of luminal samples from the distal duodenum. Both solid and liquid gastric emptying were determined by a novel freeze-drying method developed in our laboratory. A freeze-dried standard meal (100 g, 400 kcal) was given with 100 ml normal saline containing 15 g of polyethylene glycol as a liquid marker. Gastric muscle contractility was measured by means of a force transducer implanted on the gastric antrum. EM574 (3-30 microgram/kg) and cisapride (0.3-3.0 mg/kg) were administered intraduodenally at the start of feeding. Clonidine (3-30 microgram/kg) was injected subcutaneously 15 min before feeding to induce gastroparesis. EM574 and cisapride both enhanced gastric muscle contractility in a dose-dependent manner. EM574 (30 microgram/kg and 10 microgram/kg) significantly accelerated gastric emptying of solids and liquids, respectively. Cisapride (1 mg/kg) significantly accelerated solid gastric emptying, but 3.0 mg/kg significantly delayed liquid gastric emptying. Clonidine (10 and 30 microgram/kg) significantly delayed solid and liquid gastric emptying and reduced gastric muscle contractility. EM574, at a dose of 30 microgram/kg, completely restored solid and liquid gastric emptying and muscle contractility to the normal range in dogs with clonidine-induced gastroparesis. Cisapride (1 mg/kg) restored liquid gastric emptying in dogs with gastroparesis to the normal range and partially restored solid emptying. EM574 accelerated gastric muscle contractility and emptying of solids and liquids in normal dogs. The stimulating activity of EM574 on gastric muscle contractility and emptying was comparable to that of cisapride, but EM574 was as effective as cisapride in normalizing gastric muscle contractility and emptying in dogs with clonidine-induced gastroparesis.
机译:EM574是一种红霉素衍生物和强力的胃动素受体激动剂,目前正在作为胃动力药进行临床试验。这项研究的目的是比较EM574和西沙必利对正常和胃轻瘫犬胃动力和排空的影响。六只狗各植入两个十二指肠插管,用于将苯酚磺酞注入十二指肠近端,并从十二指肠远端抽吸腔内样品。固体和液体胃排空均通过我们实验室开发的新型冷冻干燥方法确定。冷冻干燥的标准餐(100 g,400 kcal)中加入100 ml生理盐水,其中含有15 g聚乙二醇作为液体标记。胃肌收缩力是通过植入胃窦的力传感器测量的。喂食开始时经十二指肠内给予EM574(3-30微克/千克)和西沙必利(0.3-3.0毫克/千克)。喂食前15分钟皮下注射可乐定(3-30微克/千克),以诱发胃轻瘫。 EM574和西沙必利均以剂量依赖性方式增强胃肌收缩力。 EM574(30微克/千克和10微克/千克)分别显着加速了固体和液体的胃排空。西沙必利(1 mg / kg)显着促进固体胃排空,但3.0 mg / kg显着延迟液体胃排空。可乐定(10和30微克/千克)显着延迟了固体和液体胃排空并降低了胃肌收缩力。 EM574的剂量为30微克/千克,将可乐定诱发的胃轻瘫犬的固体和液体胃排空和肌肉收缩力完全恢复到正常范围。西沙必利(1 mg / kg)将胃轻瘫犬的液体胃排空恢复到正常范围,并部分恢复固体排空。 EM574加速了正常犬的胃肌收缩力和固体和液体的排空。 EM574对胃肌收缩力和排空的刺激活性与西沙必利相当,但EM574与西沙必利在可乐定诱发的胃轻瘫犬的正常胃肌收缩和排空方面一样有效。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号